Baird Maintains Outperform on Twist Bioscience, Lowers Price Target to $135

Benzinga · 2d ago
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $187 to $135.